Decision Analysis and Cost-Effectiveness Analysis

Seminars in Spine Surgery

Volumn 21, Issue 4, 2009, Pages 216-222

  Ryder, Hilary F ^a   McDonough, Christene M ^b,c   Tosteson, Anna N A ^a   Lurie, Jon D ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^c BOSTON UNIVERSITY   (United States)

Author keywords

cost effectiveness analysis; decision analysis; medical decision making

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; EXPERIENCE; HEALTH CARE; HEALTH CARE COST; HUMAN; LIFE EXPECTANCY; LUMBAR DISK HERNIA; MATHEMATICAL ANALYSIS; MEDICAL DECISION MAKING; MEDICAL PRACTICE; MEDICARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; SENSITIVITY ANALYSIS; SPINE SURGERY;

EID: 70450245385     PISSN: 10407383     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semss.2009.08.003     Document Type: Article

References (41)

1. Sox H., Blatt M., Higgins M., et al. Medical Decision Making. (ed 2) (2007), American College of Physicians, Philadelphia, PA
2. Hunink M., Glasziou P., Siegel J., et al. Decision Making in Health and Medicine: Integrating Evidence and Values (2001), Cambridge University Press, Cambridge
3. Von Neumann J., and Morgenstern O. Theory of Games and Economic Behavior (1944), Princeton University Press, Princeton, NJ
4. Torrance G., Feeny D., and Furlong W. Visual analog scales: do they have a role in the measurement of preferences for health states?. Med Decis Mak 21 (2001) 329-334
5. Parkin D., and Devlin N. Is there a case for using visual analogue scale valuations in cost-utility analysis?. Health Econ 15 (2006) 653-664
6. Bleichrodt H. A new explanation for the difference between time trade-off utilities and standard gamble utilities. Health Econ 11 (2002) 447-456
7. Torrance G., Furlong W., and Feeny D. Health utility estimation. Expert Rev Pharmacoecon Outcomes Res 2 (2002) 99-108
8. van Osch S., Wakker P., van den Hout W., et al. Correcting biases in standard gamble and time tradeoff utilities. Med Decis Mak 24 (2004) 511-517
9. Peul W., van den Hout W., Brand R., et al. Prolonged conservative care versus early surgery in patients with sciatica caused by lumbar disc herniation: two year results of a randomised controlled trial. BMJ 336 (2008) 1355-1358
10. Weinstein J., Lurie J., and Tosteson T. Surgical vs nonoperative treatment for lumbar disc herniation: the spine patient Outcomes Research Trial (SPORT) observational cohort. JAMA 296 (2006) 2451-2459
11. Weinstein J., Tosteson T., and Lurie J. Surgical vs nonoperative treatment for lumbar disk herniation: the Spine Patient Outcomes Research Trial (SPORT): a randomized trial. JAMA 296 (2006) 2441-2450
12. Gold M., Siegel J., Russell L., et al. Cost-effectiveness in Health and Medicine (1996), Oxford University Press, New York
13. Dawson B., and Trapp R. Basic and Clinical Biostatistics. (ed 4) (2004), Lange Medical, New York
14. Richardson G., and Manca A. Calculation of quality adjusted life years in the published literature: a review of methodology and transparency. Health Econ 13 (2004) 1203-1210
15. Brooks R. EuroQol: the current state of play. Health 37 (1996) 53-72
16. Dolan P. Modelling valuations for EQ-5d health states. An alternative model using differences in valuations. Med Care 40 (2002) 442-446
17. Torrance G., Furlong W., Feeny D., et al. Multi-attribute preference functions. Health utilities index. Pharmacoeconomics 7 (1995) 503-520
18. Kaplan R., and Anderson J. A general health policy model: update and applications. Health Serv Res 23 (1988) 203-235
19. Brazier J., Roberts J., and Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 21 (2002) 271-292
20. Pauker S., and Kassirer J. Decision analysis. N Engl J Med 316 (1987) 250-258
21. Weinstein M., and Stason W. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 296 (1977) 716-721
22. Drummond M., O'Brian B., Stoddart G., et al. Methods for the Economic Evaluation of Health Care Programmes. (ed 2) (1997), Oxford University Press, New York
23. Weinstein M., Siegel J., Gold M., et al. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 276 (1996) 1253-1258
24. Russell L., Gold M., Siegel J., et al. The role of cost-effectiveness analysis in health and medicine. JAMA 276 (1996) 1172-1177
25. Evans C., Tavakoli M., and Crawford B. Use of quality adjusted life years and life years gained as benchmarks in economic evaluation: a critical appraisal. Health Care Manage Sci 7 (2004) 43-49
26. Kassirer J., and Angell M. The Journal's policy on cost-effectiveness analyses. N Engl J Med 331 (1994) 669-670
27. Hansson E., and Hansson T. The cost-utility of lumbar disc herniation surgery. Eur Spine J 16 (2007) 329-337
28. Tosteson A., Skinner J., Tosteson T., et al. The Cost Effectiveness of surgical versus nonoperative treatment for lumbar disc herniation over two years. Spine 33 (2008) 1-8
29. Malter A., Larson E., Urban N., et al. Cost-effectiveness of lumbar discectomy for the treatment of herniated intervertebral disc. Spine 21 (1996) 1048-1054
30. Atlas S., Deyo R., and Keller R.B. The Maine lumbar spine study. Part II. 1-Year outcomes of surgical and nonsurgical management of sciatica. Spine 21 (1996) 1777-1786
31. van den Hout W., Peul W., Koes B., et al. Prolonged conservative care versus early surgery in patients with sciatica from lumbar disc herniation: cost utility analysis alongside a randomised controlled trial. BMJ 336 (2008) 1351-1354
32. Siegel J., Weinstein M., Russell L., et al. Recommendations for reporting cost-effectiveness analyses. JAMA 276 (1996) 1339-1341
33. Chapman R., Berger M., Weinstein M., et al. When does quality-adjusting life-years matter in cost-effectiveness analysis?. Health Econ 13 (2004) 429-436
34. Donaldson C., Currie G., and Mitton C. Cost effectiveness analysis in health care: contraindications. BMJ 325 (2002) 891-894
35. Neumann P., Greenberg D., Olchanski N., et al. Growth and quality of the cost-utility literature, 1976-2001. Value Health 8 (2005) 3-9
36. Bloom B. Use of formal benefit/cost evaluations in health care decision making. Am J Manag Care 10 (2004) 329-335
37. Siegel J. Cost-effectiveness analysis in US healthcare decision-making: where is it going?. Med Care 43 suppl 7 (2005) II1-II4
38. Aspinall S., Good C., Glassman P., et al. The evolving use of cost-effectiveness analysis in formulary management within the Department of Veteran Affairs. Med Care 43 suppl 7 (2005) II20-II26
39. Guyatt G., Baumann M., Paulker S., et al. Addressing resource allocation issues in recommendations from clinical practice guideline panels: suggestions from an American College of Chest Physicians task force. Chest 129 (2006) 182-187
40. Luce B. What will it take to make cost-effectiveness analysis acceptable in the United States?. Med Care 43 suppl 7 (2005) II44-II48
41. Tunis S. Economic analysis in healthcare decisions. Am J Manag Care 10 (2004) 301-304